Fundraising Fox

Scorpion Therapeutics

Boston, US · Founded 2020 · Delaware corporation · 8 known investors

scorpiontx.com ↗
Biotech

Founders & leadership

AF
Adam FriedmanExecutive Officer, Director
AF
Andrew FedderExecutive Officer
DS
Darrin StuartExecutive Officer
EJ
Erica JacksonExecutive Officer
AV
Amanda ValentinoExecutive Officer
GG
Gary GlickExecutive Officer, Director
PJ
Peter Joseph Campisi, Jr.Executive Officer
ON
Oleg NodelmanDirector
OS
Otello StampacchiaDirector
SC
Shelley ChuDirector
JF
Jean-Francois FormelaDirector
SS
Saurabh SahaDirector

Investors · 8

Atlas VentureCambridge · $500K – $1Mvia Jean-François Formela · board
Avoro Capital AdvisorsNew York
EcoR1 CapitalSan Franciscovia Oleg Nodelman · board
Frazier Life SciencesPalo Altovia Kevin Li · led
Nextech InvestZurich · $648K – $3.2M
Vida VenturesLos Angeles
Olive Tree CapitalreportedBoston
Omega FundsreportedBoston

Reported raises · per SEC filings

Form D private placements
▶$125.7MraisedJul 2024 · 38 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew FedderExecutive Officer
  • Oleg NodelmanDirector
  • Otello StampacchiaDirector
  • Adam FriedmanExecutive Officer, Director
  • Shelley ChuDirector
  • Darrin StuartExecutive Officer
  • Erica JacksonExecutive Officer
  • Jean-Francois FormelaDirector
  • Amanda ValentinoExecutive Officer
  • Jeffrey AlbersDirector
  • Saurabh SahaDirector
  • Arjun GoyalDirector
  • Keith FlahertyDirector
  • Mark ChaoExecutive Officer
  • Brian PiperExecutive Officer
Offering amount
$150M
Amount sold
$125.7M
First sale
Jul 2024
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$147MraisedDec 2020 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jean-Francois FormelaDirector
  • Arjun GoyalDirector
  • Peter Joseph Campisi, Jr.Executive Officer
  • Keith FlahertyDirector
  • Otello StampacchiaDirector
  • Shelley ChuDirector
  • Gary GlickExecutive Officer, Director
Amount sold
$147M
First sale
Nov 2020
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$24.7MraisedMay 2020 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Gary GlickExecutive Officer, Director
  • Peter Joseph Campisi, Jr.Executive Officer
Amount sold
$24.7M
First sale
Apr 2020
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.